aarec filia research/afr oncology

AFR Oncology is a CRO created in 2010, dedicated to research in oncology. Our company establish tailor-made research programs for academic partners, biotechnology companies and pharmaceutical industries. Our company aim to facilitate the development and set-up of preclinical, translational, and clinical projects at each stage of bench-to-bedside continuum. Our philosophy rely on a strong mentoring network of cancer professionals to support constructive approaches and to improve decision-making process. - Tailor-made research, fast and efficient, to meet the needs of our clients - Solid preclinical, translational and clinical expertise to develop your projects in compliance with GLP, ICH-GCP, and ISO certification - Validation of drug proof-of-concept (efficacy, MoA, and effect on cellular activities) - Strong expertise on signaling pathways involved in tumor progression - Regulatory intelligence, submission and/or notifications to local competent authorities and regulatory bodies - Strong expertise on conduct of Phase I to Phase IV & Observational oncology clinical trials - End to end clinical trial management (from start-up activities to the end of the trial)